LIU DONGFANG (Chief Medical Officer) sold 89.3% of their position (150K shares) of NUVATION BIO INC. on the open market
Open‑market sale worth $1.17M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/3/2025ACC: 0001937915-25-000010
Officer· Chief Medical Officer
Since Jul 2022
-150K
Net shares
Net seller
$1.17M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
150K acquired · 300K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
+150K
Price / share
$2.93
Trade value
$439.50K
% of position
833.3%
12/1/2025
18K→168K
Class A Common Stock
Direct
Shares
−150K
Price / share
$7.82
Trade value
$1.17M
% of position
89.3%
12/1/2025
168K→18K
Total
Net shares
+0.00
Net value
-$733.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 12/1/2025 | M · Option Exercise | +150K | $2.93 | $439.50K | 833.3% | 18K | 168K |
| Class A Common Stock Direct | 12/1/2025 | S · Sale | −150K | $7.82 | $1.17M | 89.3% | 168K | 18K |
| Total | +0.00 | -$733.75K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Class A Common Stock
150K shares
Shares
−150K
Strike price
2.93
Held after
165K
Exercisable
—
12/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock150K shares | 12/1/2025 | M · Option Exercise | −150K | 2.93 | — | 165K |